Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2780150 | 0.76 | FDPS (0.32) | TSHRSMPD1 | |
| SCHEMBL17374685 | 0.70 | FDPS (0.34) | SMPD1 | |
| SCHEMBL93262 | 0.70 | FDPS (0.34) | SMPD1 | |
| SCHEMBL8486541 | 0.69 | ACE2 (0.41) | SMPD1 | |
| SCHEMBL695769 | 0.69 | TSHR (0.42) | TSHRSMPD1 | |
| SCHEMBL2110487 | 0.68 | GGPS1 (0.38) | SMPD1 | |
| SCHEMBL93145 | 0.68 | GGPS1 (0.38) | SMPD1 | |
| SCHEMBL2111010 | 0.68 | GGPS1 (0.38) | SMPD1 | |
| SCHEMBL2110792 | 0.68 | GGPS1 (0.38) | SMPD1 | |
| SCHEMBL2107758 | 0.68 | GGPS1 (0.38) | SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3177297-B1 | COMPOSITIONS RELATING TO VITAMIN D | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2021-04-07 | — | — | EP | disclosed |
| EP-3161005-B1 | BINDING PARTNERS SPECIFIC FOR VITAMIN D EPIMERS IN VITAMIN D ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2020-11-25 | — | — | EP | disclosed |
| US-10399938-B2 | Compositions relating to vitamin D | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2019-09-03 | — | — | US | disclosed |
| EP-3161006-B1 | ASSAYS FOR VITAMIN D EPIMERS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-20190016677-A1 | COMPOSITIONS RELATING TO VITAMIN D | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2019-01-17 | — | — | US | disclosed |
| US-10106498-B2 | Compositions relating to vitamin D | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2018-10-23 | — | — | US | disclosed |
| US-9815907-B2 | Binding partners specific for vitamin D epimers | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-11-14 | — | — | US | disclosed |
| US-9804176-B2 | Assays for vitamin D epimers | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-9777069-B2 | Compositions and methods for detection of methadone metabolite | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-10-03 | — | — | US | disclosed |
| US-9746484-B2 | Binding partners specific for vitamin D epimers in vitamin D assays | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-08-29 | — | — | US | disclosed |
| WO-2005058864-A1 | ASSAY FOR ENTACTOGENS | DADE BEHRING INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050130225-A1 | Ecstasy haptens and immunogens | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2005-06-16 | — | — | US | disclosed |
| US-20050130243-A1 | Assay for entactogens | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2005-06-16 | — | — | US | disclosed |
| US-20050130244-A1 | for detection of 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-methamphetamine (MDMA) anibody production; drug screening; haptens; immunogens | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2005-06-16 | — | — | US | disclosed |
| WO-2004032845-A2 | R-NSAID ESTERS AND THEIR USE | ENCORE PHARMACEUTICALS, INC. (US) | 2004-04-22 | — | — | WO | disclosed |
| US-20040067914-A1 | R-NSAID esters and their use | ENCORE PHARMACEUTICALS, INC. | 2004-04-08 | — | — | US | disclosed |
| US-6582700-B1 | A linear core chain having two or more side chains pending directly from different points on the linear core chain. Each of the side chains comprises an epitopic site of an antigen or a peptide. The synthetic constructs are monomeric units that | MEDICAL UNIVERSITY OF SOUTH CAROLINA | 2003-06-24 | — | — | US | disclosed |
| EP-1032422-A4 | LINEAR ANTIGEN SUPPORTING UNITS | UNIV SOUTH CAROLINA (US) | 2003-02-05 | — | — | EP | disclosed |
| EP-1032422-A1 | LINEAR ANTIGEN SUPPORTING UNITS | MEDICAL UNIVERSITY OF SOUTH CAROLINA (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999025381-A1 | LINEAR ANTIGEN SUPPORTING UNITS | MEDICAL UNIVERSITY OF SOUTH CAROLINA (US) | 1999-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067914-A1 | R-NSAID esters and their use | PTGS1, PTGES, NAPEPLD | TSHR 4232/4885SMPD1 2486/4885 |
| US-10399938-B2 | Compositions relating to vitamin D | CYP24A1, CYP2R1, VDR | TSHR 649/4885SMPD1 998/4885 |
| US-10106498-B2 | Compositions relating to vitamin D | VDR, CYP24A1, CYP2R1 | TSHR 339/4885SMPD1 496/4885 |
| US-20050130243-A1 | Assay for entactogens | HTR3C, COMT, PNMT | TSHR 2695/4885SMPD1 1270/4885 |
| US-20190016677-A1 | COMPOSITIONS RELATING TO VITAMIN D | CYP24A1, VDR, CYP2R1 | TSHR 807/4885SMPD1 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.